Circulating Tumor DNA Market

The global circulating tumor DNA (ctDNA) market is projected to expand from USD 7.96 billion in 2025 to approximately USD 27.67 billion by 2034, growing at a CAGR of 14.85%. This surge is driven by breakthroughs in precision oncology, rising demand for non-invasive cancer diagnostics, and advancements in next-generation sequencing (NGS) technology. What Is Driving […]